Oxford Industries executives sold thousands of shares at $44.62 just three days before the company downgraded its 2026 revenue guidance, causing the stock to plunge 17%. The company lowered its full-year revenue midpoint to $1.49 billion and forecasted Q2 sales about 5.8% below analyst estimates. This has triggered an investigation into whether executives had material non-public information when selling shares. Shareholders who suffered losses are encouraged to explore legal options through SueWallSt, a firm experienced in securities litigation.
Mesoblast Limited has drawn $50 million from a new five-year loan facility provided by a shareholder, replacing higher-cost short-term debt. This move strengthens Mesoblast's balance sheet by lowering interest costs and removing short-term obligation...
HUTCHMED announced positive Phase II trial results for fanregratinib in treating advanced intrahepatic cholangiocarcinoma (ICC) with FGFR2 fusion/rearrangement. The study showed a 42.5% objective response rate and median overall survival of 16.6 mont...
Western Union and Intermex announced that regulatory approvals for Western Union's acquisition of Intermex have been received from 51 U.S. states and international jurisdictions, with only one U.S. state, New York, pending approval. Both companies ar...
Modern Therapy Group has introduced a virtual intensive outpatient program (IOP) designed for adults dealing with depression, anxiety, trauma, and other mental health issues. This program offers structured, clinician-led treatment five days a week vi...
Meyer Wilson Werning, an investor protection law firm, is investigating UBS advisor Daniel Merithew Allen for allegedly recommending unapproved investments in 99 Acquisition Group LLC to clients. This practice, known as "selling away," violates FINRA...
